Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ESMO open

Showing results (141-150 of 2,246) with videos related to

Pageof 225
Sort By:
ESMO Open|November 14, 2024
Determining fitness for enfortumab vedotin and pembrolizumab in metastatic bladder cancer: the time to move beyond isolated comorbidity assessmentsB M Russell, D E C Fein, J Bellmunt
ESMO Open|August 25, 2023
The paradigm shift to precision oncology between political will and cultural acceptanceE Rassy, J-M Heard, F Andre
ESMO Open|October 17, 2022
Symptom burden, psychological distress, and symptom management status in hospitalized patients with advanced cancer: a multicenter study in ChinaY He, Y Pang, Z Su, et al.
ESMO Open|September 26, 2022
Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatmentE Su, S Fischer, R Demmer-Steingruber, et al.
ESMO Open|September 26, 2022
The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regressionC M Kim, J B Lee, S J Shin, et al.
ESMO Open|January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapyZ L R Kaplan, N van Leeuwen, D van Klaveren, et al.
ESMO Open|January 28, 2025
Psychiatric disorders in adolescent and young adult cancer survivors in KoreaS-M Jeong, D Kang, H Kim, et al.
ESMO Open|January 28, 2025
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)P G Casali, H Antoine-Poirel, S Berrocoso, et al.
ESMO Open|January 15, 2025
Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomesW Xu, G Birch, A Meliki, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
Pageof 225

Showing results (141-150 of 2,246) with videos related to

Sort By:
Pageof 225
ESMO Open|November 14, 2024
Determining fitness for enfortumab vedotin and pembrolizumab in metastatic bladder cancer: the time to move beyond isolated comorbidity assessmentsB M Russell, D E C Fein, J Bellmunt
ESMO Open|August 25, 2023
The paradigm shift to precision oncology between political will and cultural acceptanceE Rassy, J-M Heard, F Andre
ESMO Open|October 17, 2022
Symptom burden, psychological distress, and symptom management status in hospitalized patients with advanced cancer: a multicenter study in ChinaY He, Y Pang, Z Su, et al.
ESMO Open|September 26, 2022
Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatmentE Su, S Fischer, R Demmer-Steingruber, et al.
ESMO Open|September 26, 2022
The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regressionC M Kim, J B Lee, S J Shin, et al.
ESMO Open|January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapyZ L R Kaplan, N van Leeuwen, D van Klaveren, et al.
ESMO Open|January 28, 2025
Psychiatric disorders in adolescent and young adult cancer survivors in KoreaS-M Jeong, D Kang, H Kim, et al.
ESMO Open|January 28, 2025
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)P G Casali, H Antoine-Poirel, S Berrocoso, et al.
ESMO Open|January 15, 2025
Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomesW Xu, G Birch, A Meliki, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
Pageof 225